Quick Take Ozempic Established medication already on the market Contains semaglutide Part of the GLP-1 weight loss drugs conversation Better known in real-world care Retatrutide Newer investigational option Still in retatrutide clinical trials Often discussed as part of new weight loss medications Not FDA approved as of March 25, 2026 Bottom line If you want an option that is currently established and available through normal prescribing channels for approved uses, Ozempic is the more practical choice today
Compared to MT1 and alpha-MSH, the cyclic form of MT2 boosts affinity towards various melanocortin receptors, namely MC1R and MC4R
Rare but serious concerns include pancreatitis and gallbladder disease, so report severe abdominal pain or persistent vomiting right away
This circumstance exemplifies todays global health dilemma, which alarms the inadequacy of ongoing efforts to address the existing health concerns worldwide
All prescription medications, including compounded ones, require a prescription from a licensed healthcare provider
Feb 2001;86(2):724-31